Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Diab

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Cancer|August 10, 2019
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanomaGustavo Schvartsman, Junsheng Ma, Roland L Bassett, et al.
Endocrine-Related Cancer|April 23, 2021
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patternsHa Nguyen, Komal Shah, Steven G Waguespack, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
NPJ Breast Cancer|April 20, 2022
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastasesDavid B Page, Kathryn Beal, Stefanie N Linch, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
Inflammatory Bowel Diseases|May 3, 2018
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related ColitisYinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.
Journal of Cutaneous Pathology|September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patientsMichael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
Cancers|January 1, 2020
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral MelanomaDinesh Pradhan, George Jour, Denái Milton, et al.
Cancer Discovery|April 17, 2019
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid TumorsSalah-Eddine Bentebibel, Michael E Hurwitz, Chantale Bernatchez, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Cancer|August 10, 2019
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanomaGustavo Schvartsman, Junsheng Ma, Roland L Bassett, et al.
Endocrine-Related Cancer|April 23, 2021
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patternsHa Nguyen, Komal Shah, Steven G Waguespack, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
NPJ Breast Cancer|April 20, 2022
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastasesDavid B Page, Kathryn Beal, Stefanie N Linch, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
Inflammatory Bowel Diseases|May 3, 2018
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related ColitisYinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.
Journal of Cutaneous Pathology|September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patientsMichael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
Cancers|January 1, 2020
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral MelanomaDinesh Pradhan, George Jour, Denái Milton, et al.
Cancer Discovery|April 17, 2019
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid TumorsSalah-Eddine Bentebibel, Michael E Hurwitz, Chantale Bernatchez, et al.
Pageof 14